1. Home
  2. AREC vs CNTX Comparison

AREC vs CNTX Comparison

Compare AREC & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREC
  • CNTX
  • Stock Information
  • Founded
  • AREC 2013
  • CNTX 2015
  • Country
  • AREC United States
  • CNTX United States
  • Employees
  • AREC 26
  • CNTX N/A
  • Industry
  • AREC Coal Mining
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREC Energy
  • CNTX Health Care
  • Exchange
  • AREC Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • AREC 37.9M
  • CNTX 60.7M
  • IPO Year
  • AREC 2019
  • CNTX 2021
  • Fundamental
  • Price
  • AREC $0.50
  • CNTX $0.66
  • Analyst Decision
  • AREC Strong Buy
  • CNTX Strong Buy
  • Analyst Count
  • AREC 3
  • CNTX 5
  • Target Price
  • AREC $4.33
  • CNTX $6.50
  • AVG Volume (30 Days)
  • AREC 1.4M
  • CNTX 73.1K
  • Earning Date
  • AREC 05-20-2025
  • CNTX 03-20-2025
  • Dividend Yield
  • AREC N/A
  • CNTX N/A
  • EPS Growth
  • AREC N/A
  • CNTX N/A
  • EPS
  • AREC N/A
  • CNTX N/A
  • Revenue
  • AREC $399,962.00
  • CNTX N/A
  • Revenue This Year
  • AREC N/A
  • CNTX N/A
  • Revenue Next Year
  • AREC $3,208.62
  • CNTX N/A
  • P/E Ratio
  • AREC N/A
  • CNTX N/A
  • Revenue Growth
  • AREC N/A
  • CNTX N/A
  • 52 Week Low
  • AREC $0.41
  • CNTX $0.64
  • 52 Week High
  • AREC $1.59
  • CNTX $2.75
  • Technical
  • Relative Strength Index (RSI)
  • AREC 46.96
  • CNTX 38.61
  • Support Level
  • AREC $0.51
  • CNTX $0.64
  • Resistance Level
  • AREC $0.63
  • CNTX $0.99
  • Average True Range (ATR)
  • AREC 0.07
  • CNTX 0.09
  • MACD
  • AREC 0.01
  • CNTX -0.00
  • Stochastic Oscillator
  • AREC 44.91
  • CNTX 4.31

About AREC American Resources Corporation

American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: